Organometallics
Article
stirred overnight before removal of the volatiles under vacuum. The
crude product was dissolved in acetonitrile (15 mL) and filtered to
remove precipitated silver chloride. The solvent was removed under
vacuum, and the crude product was recrystallized from a pentane/
dichloromethane mixture. 3a was isolated in 85% yield (79 mg, 1.9
mmol). ESI-MS (m/z): 403, MW 403. Anal. Calcd for C14H18N3PdCl2:
(m, 3 H, p-Ar-CH3), 2.13 (s, 6H, o-Ar-CH3), 1.34 (d, 6H, iPr-CH3), 1.14
(d, 6H, iPr-CH3), 0.27 (s, 3H, Pd-CH3). 13C NMR (75 MHz, CD3CN):
δ 179.1, 164.1, 145.8, 140.1, 134.3, 131.7, 129.3, 128.5, 124.1, 33.8, 28.8,
28.6, 25.9, 22.6, 20.9, −5.9.
Synthesis of [(3-Me-1-(2,6-diisopropylphenyl)iminyl-C3H2N2)-
PdMeCH3CN]+BAF− (5c). NaBAF (443 mg, 0.5 mmol) was added to a
solution of 4c (220 mg, 0.5 mmol) in MeCN (10 mL) and stirred at
room temperature for 16 h with exclusion from light. The reaction
mixture was then filtered through Celite, and the volatiles were removed
under reduced pressure. The resulting off-white solid was dissolved in
CH2Cl2 (5 mL), and the solution was stirred with activated charcoal for
30 min. The mixture was then filtered through Celite and concentrated
to 2 mL. An off-white solid was precipitated by addition of excess n-
hexane, filtered, and dried under vacuum. 5c was isolated in 95% yield
(640 mg, 0.48 mmol). ESI-MS (m/z): 405, [NHC-Pd-CH3]+ 405. Anal.
Calcd for C53H44N4BF24Pd: C, 48.44; H, 3.68; N, 4.26. Found: C, 48.33;
H, 3.56; N, 4.24. 1H NMR (300 MHz, CD3Cl): 7.68 (s, 12H, BAF Ar-
H), 7.51 (m, 3H, Ar-H), 7.11 (s, 1H, imidazole-H), 6.71 (s, 1H,
imidazole-H), 3.73 (s, 3H, N−CH3), 2.85 (m, 2H, iPr-CH), 2.22 (s, 3H,
imine-CH3), 1.59 (s, 3H, CH3CN), 1.23 (d, 6H, iPr-CH3), 1.13 (d, 6H,
iPr-CH3), 0.87 (s, 3H, Pd-CH3). 13C NMR (75 MHz, CD3CN): δ 173.5,
1
C, 41.45; H, 4.47; N, 10.36. Found: C, 41.64; H, 4.51; N, 10.28. H
NMR (300 MHz, DMSO-d6): δ = 8.05 (d, 1H, imidazole-H), 7.52 (d,
1H, imidazole-H), 7.07 (m, 3H, Ar-H), 4.11 (s, 3H, N-CH3), 2.25 (s,
3H, imine-CH3), 2.15 (s, 6H, o-Ar-CH3). 13C NMR (75 MHz, DMSO-
d6): δ 165.5, 157.2, 142.1, 131.8, 128.4, 125.6, 119.4, 38.0, 18.9, 15.4.
Synthesis of [3-Me-1-(2,4,6-trimethylphenyl)iminyl-C3H2N2]PdCl2
(3b). Following the above procedure, 3b was isolated in 74% yield (71.1
mg, 0.2 mmol). ESI-MS (m/z): 418, MW 418. Anal. Calcd for
C15H20N3PdCl2: C, 42.93; H, 4.80; N, 10.01. Found: C, 42.99; H, 4.72;
N, 10.12. 1H NMR (300 MHz, DMSO-d6): δ 8.03 (d, 2H, imidazole-H),
7.51 (d, 2H, imidazole-H), 6.87 (m, 2H, Ar-H), 4.10 (s, 3H, N-CH3),
2.22 (s, 6H, o-Ar-CH3), 2.11 (m, 3H, imine-CH3), 2.09 (m, 3H, p-Ar-
CH3). 13C NMR (75 MHz, DMSO-d6): δ 157.6, 150.6, 146.1, 139.8,
138.3, 135.4, 131.5, 129.0, 125.6, 117.5, 38.3, 21.4, 18.9, 15.4.
Synthesis of [3-Me-1-(2,6-diisopropylphenyl)iminyl-C3H2N2]PdCl2
(3c). Following the above procedure, 3c was isolated in 77% yield (81.4
mg, 0.2 mmol). ESI-MS (m/z): 458, MW 458. Anal. Calcd for
C18H26N3PdCl2: C, 46.82; H, 5.68; N, 9.10. Found: C, 46.98; H, 5.75; N,
8.98. 1H NMR (300 MHz, DMSO-d6): δ 7.73 (s, 1H, imidazole-H), 7.33
(s, 1H, imidazole-H), 7.10 (m, 3H, Ar-H), 4.26 (s, 3H, N-CH3), 3.08
168.0, 167.4, 166.7, 166.4, 145.5, 143.9, 140.1, 134.6, 134.2, 131.7, 129.2,
128.1, 43.3, 33.8, 28.5, 28.4, 20.6, −6.3.
Synthesis of [(3-(2, 4, 6-trimethylphenyl)-1-(2, 6-
diisopropylphenyl)iminyl-C3H2N2)PdMeCH3CN]+BAF− (5e). Following
the above procedure, 5e was isolated in 98% yield (704 mg, 0.49 mmol).
ESI-MS (m/z): 509, [NHC-Pd-CH3]+ 509. Anal. Calcd for
C61H52N4BF24Pd: C, 51.66; H, 3.98; N, 3.95. Found: C, 51.47; H,
3.88; N, 3.85. 1H NMR (300 MHz, CD3Cl): δ 7.67 (s, 8H, BAF Ar-H),
7.50 (m, 4H, BAF Ar-H), 7.32 (m, 3H, Ar-H), 6.98 (s, 3H, imidazole-H,
(m, 2H, iPr-CH), 2.31 (s, 3H, imine-CH3), 1.25 (d, 12H, iPr-CH3). 13
C
NMR (75 MHz, DMSO-d6): δ 165.3, 157.1, 142.6, 139.1, 136.4, 129.0,
125.7, 123.9, 120.7, 119.5, 38.4, 28.3, 24.5, 16.3.
Synthesis of [3-(2,4,6-trimethylphenyl)-1-(2,6-dimethylphenyl)-
iminyl-C3H2N2]PdCl2 (3d). Following the above procedure, 3d was
isolated in 80% yield (94 mg, 0.18 mmol). ESI-MS (m/z): 506, MW 506.
Anal. Calcd for C22H26N3PdCl2: C, 51.83; H, 5.14; N, 8.24. Found: C,
51.92; H, 5.22; N, 8.13. 1H NMR (300 MHz, DMSO-d6): δ 8.31 (s, 1H,
imidazole-H), 7.51 (s, 1H, imidazole-H), 7.08 (m, 5H, C6H3, C6H2),
2.29 (s, 3H, imine-CH3), 2.19 (s, 3H, p-Ar-CH3), 2.06 (m, 12H, o-Ar-
CH3). 13C NMR (75 MHz, DMSO-d6): δ 165.1, 159.7, 142.0, 139.0,
134.4, 131.8, 128.4, 125.3, 123.9, 21.5, 18.9, 18.4, 15.7.
Synthesis of [3-(2,4,6-trimethylphenyl)-1-(2,6-diisopropylphenyl)-
iminyl-C3H2N2]PdCl2 (3e). Following the above procedure, 3e was
isolated in 85% yield (110 mg, 0.20 mmol). ESI-MS (m/z): 562, MW
562. Anal. Calcd for C26H34N3PdCl2: C, 55.18; H, 6.06; N, 7.43. Found:
C, 55.25; H, 6.13; N, 7.32.1H NMR (300 MHz, DMSO-d6): δ 8.24 (d,
1H, imidazole-H), 7.53 (d, 1H, imidazole-H), 7.18 (m, 5H, C6H3,
C6H2), 3.08 (m, 2H, iPr-CH), 2.39 (s, 3H, imine-CH3), 2.07 (s, 6H, o-
Ar-CH3), 1.28 (d, 12H,iPr-CH3). 13C NMR (75 MHz, DMSO-d6): δ
165.4, 159.9, 145.2, 141.7, 139.1, 134.3, 129.1, 125.3, 124.0, 120.4, 109.9,
28.8, 24.5, 24.1, 21.5, 18.4, 16.4.
i
Ar-H), 6.84 (s, 1H, imidazole-H), 2.85 (m, 2H, Pr-CH), 2.36 (s, 3H,
imine-CH3), 2.28 (m, 3H, p-Ar-CH3), 1.64 (s, 3H, CH3CN), 1.23 (d,
6H, iPr-CH3), 1.18 (d, 6H, iPr-CH3), 0.07 (s, 3H, Pd-CH3). 13C NMR
(75 MHz, CD3CN): δ 175.4, 168.1, 167.4, 166.7, 166.1, 165.9, 145.5,
140.2, 135.1, 134.7, 134.5, 134.3, 132.8, 131.8, 130.0, 129.3, 128.2, 125.4,
33.8, 28.5, 25.7, 22.3, 20.6, −5.8.
ASSOCIATED CONTENT
* Supporting Information
■
S
Figures, tables, and CIF files giving detailed NMR sepctra,
crystallographic data of palladium complexes 3a−c,e, 4c,e, and
5c,e, 1H NMR spectroscopy of 5e with norbornene at different
times, and IR and WAXD of the PNB. This material is available
AUTHOR INFORMATION
Corresponding Author
■
Synthesis of [3-Me-1-(2,6-diisopropylphenyl)iminyl-C3H2N2]-
PdMeCl (4c). A solution of 2c (425 mg, 1 mmol) in CH2Cl2 (40 mL)
was added dropwise to a solution of (COD)PdMeCl (263 mg, 1 mmol)
in CH2Cl2 (40 mL) and stirred at −30 °C temperature for 15 h with
exclusion from light. The reaction mixture was then filtered through
Celite, and volatiles were removed under reduced pressure. The
resulting light white solid was washed with n-hexane and dried under
vacuum. 4c was isolated in 50% yield (214 mg, 0.5 mmol). ESI-MS (m/
z): 440, MW 440. Anal. Calcd for C19H29N3PdCl: C, 51.71; H, 6.62; N,
9.52. Found: C, 51.62; H, 6.69; N, 9.47. 1H NMR (300 MHz, CD3CN):
7.85 (d, 1H, imidazole-H), 7.46 (d, 1H, imidazole-H), 7.12 (m, 3H,
C6H3), 3.75 (s, 3H, NCH3), 2.89 (m, 2H, iPr-CH), 2.19 (s, 3H, imine-
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
Financial support by the NSFC (Projects 21174164, 51173209,
and 21274167), and CNPC Innovation Foundation is gratefully
acknowledged.
REFERENCES
i
i
CH3), 1.18 (d, 6H, Pr-CH3), 1.04 (d, 6H, Pr-CH3), 0.83 (s, 3H, Pd-
CH3). 13C NMR (75 MHz, CD3CN): δ 176.1, 164.8, 145.8, 131.7,
130.1, 128.9, 128.5, 43.1, 33.8, 28.7, 28.6, 20.7, −5.4.
■
(1) (a) Arduengo, A. J.; Harlow, R. L.; Kline, M. J. Am. Chem. Soc. 1991,
113, 361. (b) Arduengo, A. J.; Dias, H. V. R.; Harlow, R. L.; Kline, M. J.
Am. Chem. Soc. 1992, 114, 5530.
Synthesis of [3-(2,4,6-trimethylphenyl)-1-(2,6-diisopropylphenyl)-
iminyl-C3H2N2]PdMeCl (4e). Following the above procedure, 4e was
isolated in 75% yield (408 mg, 0.75 mmol). ESI-MS (m/z): 544, MW
544. Anal. Calcd for C27H37N3PdCl: C, 59.45; H, 6.84; N, 7.70. Found:
C, 59.32; H, 6.83; N, 7.69. 1H NMR (300 MHz, CD3CN): 7.60 (d, 1H,
imidazole-H), 7.15 (m, 3H, imidazole-H, C6H2), 6.95 (s, 2H, C6H3),
6.78 (s, 1H, C6H3), 3.00 (m, 2H, iPr-CH), 2.35 (s, 3H, imine-CH3), 2.22
(2) (a) Jacobsena, H.; Correab, A.; Poaterb, A.; Costabile, C.; Cavallo,
L. Coord. Chem. Rev. 2009, 253, 687. (b) Herrmann, W. A. Angew. Chem.,
Int. Ed. 2002, 41, 1290.
́
(3) Dıez-Gonzalez, S.; Marion, N.; Nolan, S. T. Chem. Rev. 2009, 109,
́
3612.
(4) Yin, L.; Liebscher, L. Chem. Rev. 2007, 107, 133.
H
dx.doi.org/10.1021/om400268y | Organometallics XXXX, XXX, XXX−XXX